Abstract
Convection enhanced delivery (CED) is a promising alternative to systemic administration for bypassing the blood brain barrier, because of which most anticancer drugs are blocked in the blood circulatory system instead of concentrating in the targeted tumour tissue. As drugs are injected directly into the tumour extracellular space during CED treatment, fast drug elimination
due to physical degradation and metabolism significantly hinders effective drug penetration into large tumours, which represents one of the main limitations of CED. If drugs are encapsulated within nanoparticles which are harder for the body to eliminate, drugs can be released in a more controllable manner over time, thereby improving the potential for treatment. The present study aims to examine the impact of tumour and nanoparticle transport properties on the delivery outcomes, with the aim to optimise this drug delivery system.
due to physical degradation and metabolism significantly hinders effective drug penetration into large tumours, which represents one of the main limitations of CED. If drugs are encapsulated within nanoparticles which are harder for the body to eliminate, drugs can be released in a more controllable manner over time, thereby improving the potential for treatment. The present study aims to examine the impact of tumour and nanoparticle transport properties on the delivery outcomes, with the aim to optimise this drug delivery system.
Original language | English |
---|---|
Title of host publication | BioMedEng18 |
Subtitle of host publication | Conference Proceedings |
Publisher | BioMedEng |
Pages | 348 |
Number of pages | 1 |
ISBN (Print) | 978-1-9996465-0-9 |
Publication status | Published - 2018 |